Cargando…
Targeted radionuclide therapy /
"Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensi...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Philadelphia :
Wolters Kluwer Health/Lippincott Williams & Wilkins,
[2011]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000nam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ELB169520 | ||
| 003 | FINmELB | ||
| 005 | 20220615121057.0 | ||
| 006 | m o u | ||
| 007 | cr cnu|||||||| | ||
| 008 | 100721t20112011paua ob 001 0 eng|d | ||
| 020 | |a 9781451153262 |q (e-book) | ||
| 020 | |z 9780781796934 | ||
| 035 | |a (OCoLC)873761654 | ||
| 040 | |a FINmELB |b eng |e rda |c FINmELB | ||
| 050 | 4 | |a RC271.R26 |b T37 2011 | |
| 082 | 0 | |a 616.99/40642 |2 22 | |
| 245 | 0 | 0 | |a Targeted radionuclide therapy / |c editor, Tod W. Speer. |
| 264 | 1 | |a Philadelphia : |b Wolters Kluwer Health/Lippincott Williams & Wilkins, |c [2011] | |
| 264 | 4 | |c Ã2011 | |
| 300 | |a 1 online resource (561 pages) : |b illustrations (some color) | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a computer |2 rdamedia | ||
| 338 | |a online resource |2 rdacarrier | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a part I. Immunology and targeting constructs -- part II. The science of targeted radionuclide therapy -- part III. Tumor microenvironment and delivery strategies -- part IV. Unconjugated therapy -- part V. Conjugated therapy. | |
| 520 | |a "Radioimmunotherapy, also known as systemic targeted radiation therapy, uses antibodies, antibody fragments, or compounds as carriers to guide radiation to the targets. It is a topic rapidly increasing in importance and success in treatment of cancer patients. This book represents a comprehensive amalgamation of the radiation physics, chemistry, radiobiology, tumor models, and clinical data for targeted radionuclide therapy. It outlines the current challenges and provides a glimpse at future directions. With significant advances in cell biology and molecular engineering, many targeting constructs are now available that will safely deliver these highly cytotoxic radionuclides in a targeted fashion"--Provided by publisher. | ||
| 588 | |a Description based on metadata supplied by the publisher and other sources. | ||
| 590 | |a Electronic reproduction. Santa Fe, Arg.: elibro, 2022. Available via World Wide Web. Access may be limited to eLibro affiliated libraries. | ||
| 650 | 0 | |a Cancer |x Radioimmunotherapy. | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Speer, Tod W. | |
| 776 | 0 | 8 | |i Print version: |t Targeted radionuclide therapy. |d Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, [2011] |h xvii, 537 pages, 4 unnumbered pages of plates ; 29 cm |z 9780781796934 |w (OCoLC)ocn650953409 |w (DLC)10825376 |
| 797 | 2 | |a elibro, Corp. | |
| 856 | 4 | 0 | |u https://elibro.uam.elogim.com/ereader/bidiuam/169520 |z Texto completo |